Cargando…
Prolactin-related adverse events and change in prolactin levels in pediatric patients given antipsychotics for schizophrenia and schizophrenia spectrum disorders: A systematic review
BACKGROUND: Second-generation antipsychotics are commonly prescribed for pediatric patients with schizophrenia and schizophrenia spectrum disorders despite their lack of approval for use in children. Although considered a safer alternative to first-generation antipsychotics, there is evidence to sug...
Autores principales: | Druyts, Eric, Zoratti, Michael J., Toor, Kabirraaj, Wu, Ping, Kanji, Salmaan, Rabheru, Kiran, Mills, Edward J., Thorlund, Kristian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5101725/ https://www.ncbi.nlm.nih.gov/pubmed/27825323 http://dx.doi.org/10.1186/s12887-016-0710-y |
Ejemplares similares
-
Change in Prolactin Levels in Pediatric Patients Given Antipsychotics for Schizophrenia and Schizophrenia Spectrum Disorders: A Network Meta-Analysis
por: Balijepalli, Chakrapani, et al.
Publicado: (2018) -
The risk of elevated prolactin levels in pediatric patients exposed to antipsychotics for the treatment of schizophrenia and schizophrenia spectrum disorders: protocol for a systematic review and meta-analysis
por: Druyts, Eric, et al.
Publicado: (2014) -
Incorporating alternative design clinical trials in network meta-analyses
por: Thorlund, Kristian, et al.
Publicado: (2014) -
Prolactin and Family Psychiatric History in Schizophrenia
por: Bouguerra, I., et al.
Publicado: (2023) -
Prolactin levels and agressive behaviour in men with Schizophrenia
por: Bouguerra, I., et al.
Publicado: (2023)